Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

115.63
Delayed Data
As of Jun 24
 -1.75 / -1.49%
Today’s Change
81.79
Today|||52-Week Range
117.74
+12.57%
Year-to-Date
Bloodbath Bargains: The 10 Best Post-Brexit Stocks to Buy Now
1:58pm / TheStreet.com - Paid Partner Content
3 Safe Stocks You Can Buy Right Now
Jun 20 / MotleyFool.com - Paid Partner Content
The 5 Best Healthcare ETFs
7:22am / MotleyFool.com - Paid Partner Content
CLR,CMG, WFM: Jim Cramer's Views
Jun 20 / TheStreet.com - Paid Partner Content
What You Need to Know Before Investing in Bonds
Jun 25 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Johnson & Johnson
Jun 19 / MotleyFool.com - Paid Partner Content
3 Small-Cap Stocks to Buy in July
Jun 25 / MotleyFool.com - Paid Partner Content
1 Stock to Invest in Big Pharma
Jun 19 / MotleyFool.com - Paid Partner Content
3 Stocks with Better Dividends Than Procter & Gamble Co.
Jun 25 / MotleyFool.com - Paid Partner Content
The 3 Best Dividend Stocks for Beginning Investors
Jun 19 / MotleyFool.com - Paid Partner Content
3 Stocks to Help You Build Retirement Wealth
Jun 24 / MotleyFool.com - Paid Partner Content
Forget TransEnterix Inc: This is The Company That Intuitive Surgical Investors Should...
Jun 18 / MotleyFool.com - Paid Partner Content
New Stock Research Reports for June 24, 2016
Jun 24 / Zacks.com - Paid Partner Content
Diabetes Deep-Dive: What Investors Need to Know About This Devastating Disease
Jun 18 / MotleyFool.com - Paid Partner Content
Genmab/Novartis' Arzerra Gets Unfavorable CHMP Opinion
Jun 24 / Zacks.com - Paid Partner Content
Kura (KURA) Begins Dosing in Phase II Study on Cancer Drug
Jun 17 / Zacks.com - Paid Partner Content
Gilead's (GILD) HIV Treatment Odefsey Gains Approval in EU
Jun 24 / Zacks.com - Paid Partner Content
Wall Street heads for second straight weekly loss
Jun 17 / FT.com - Paid Partner Content
The 3 Most Important Data Releases and FDA Decisions in the Second Half of 2016
Jun 23 / MotleyFool.com - Paid Partner Content
9 Easy Ways to Lose Money in the Stock Market
Jun 17 / MotleyFool.com - Paid Partner Content
AstraZeneca Nasal Spray Flu Vaccine To be Hit By ACIP Vote
Jun 23 / Zacks.com - Paid Partner Content
Aegerion, QLT Ink Merger Deal to Form Novelion Therapeutics
Jun 17 / Zacks.com - Paid Partner Content
Stock Market News for June 22, 2016
Jun 22 / Zacks.com - Paid Partner Content
Shire Buys Global Rights to Pfizer's Gastrointestinal Drug
Jun 15 / Zacks.com - Paid Partner Content
Can These Upstarts Knock Gilead Sciences Off Its Perch?
Jun 22 / MotleyFool.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. Eli Lilly
Jun 15 / MotleyFool.com - Paid Partner Content
7 Profitable Medical Stocks Ranked as Buys Now
Jun 21 / Zacks.com - Paid Partner Content
1 Stock to Invest in Healthcare
Jun 14 / MotleyFool.com - Paid Partner Content
3 Attractive Income Stocks Whose Dividends Could Double
Jun 21 / MotleyFool.com - Paid Partner Content
At Work with the FT: Joanna Jensen, founder and CEO, Childs Farm
Jun 08 / FT.com - Paid Partner Content
Commercial Vehicle Group, Houlihan Lokey, Johnson & Johnson and Canadian Imperial Ban...
Jun 21 / Zacks.com - Paid Partner Content
Allied Minds: The search for fortune and glory
Jun 08 / FT.com - Paid Partner Content
Why Achillion Pharmaceuticals Is Down Big in 2016
Jun 20 / MotleyFool.com - Paid Partner Content
J&J to buy Vogue International for $3.3bn
Jun 02 / FT.com - Paid Partner Content
Top Stock PIcks for the Week of June 20th
Jun 20 / Zacks.com - Paid Partner Content
Corporate bonds join negative yield club
Jun 02 / FT.com - Paid Partner Content
This New Class Of Medicine Could Reshape Diabetes Treatment
Jun 20 / MotleyFool.com - Paid Partner Content
M&A back on the table as 'big pharma' targets smaller rivals
Jun 02 / FT.com - Paid Partner Content
Stock Market News for June 20, 2016
Jun 20 / Zacks.com - Paid Partner Content
Cancer doctors face next drug challenge
Jun 01 / FT.com - Paid Partner Content